Michigan department of health and human services project A6. Food defense track laboratory flexible funding model application

The Food and Drug Administration awarded the Michigan Department of Health and Human Services a cooperative agreement valued at $680,000 on September 25, 2025, under the Food and Drug Administration Research program (CFDA 93.103) to maintain laboratory capacity and operations within the food defense track of the Laboratory Flexible Funding Model.

The Michigan Bureau of Laboratories, in partnership with FDA, will attend at least two key personnel LFFM annual face-to-face meetings with oral and/or poster presentation, maintain FERN membership with annual verification, sustain a valid relationship (20.88) with FDA, and maintain facilities and personnel to ensure operational capacity. The recipient will participate in routine track webinars and meetings, provide timely response to inquiries from FDA/LFFM staff, participate in and successfully pass annual proficiency testing, engage in small-scale method development and validation work including matrix extension activities, and maintain ISO17025 accreditation. The award funds support for overflow, emergency, and surge capacity assignments to meet programmatic needs and initiatives, as well as training and mentorship to other state laboratories. All methods utilized within the track scope must comply with validation requirements.

Performance occurs at the Michigan Bureau of Laboratories in Lansing, Michigan, with a period of performance extending from September 25, 2025, through June 30, 2030.

Abstract

The michigan bureau of laboratories in partnership with FDA will maintain required aims for the food defense track. This includes attending of at least 2 key personnel lffm annual face to face meetings with oral and/or poster presentation, the maintenance of fern membership (to include annual membership verification) maintenance of a valid 20.88 with FDA, maintenance of facilities and personnel to ensure capacity, participation in routine track webinars and meetings, timely response to inquiries from FDA/lffm staff, participation and successful passing of annual proficiency testing, participation in small-scale method development, validation, and matrix extension works, support overflow, emergency, surge capacity and other assignments in a flexible manner to meet programmatic needs and initiatives, maintenance of ISO17025 accreditation, provide training and mentorship to other state laboratories, ensure methods utilized within the scope of the track are validations.